CF CF Industries Holdings, Inc.
Agricultural Chemicals · NYSE · SEC CIK 1324404 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY17.9%
TTM net income YoY58.2%
TTM EPS YoY71.5%
Revenue 3-yr CAGR1.2%
Net income 3-yr CAGR1.1%
Margins
Gross margin42.5%
Operating margin41.6%
Net margin27.5%
FCF margin26.2%
EBITDA margin53.0%
Returns
ROE41.2%
ROA14.4%
ROIC (approx.)44.2%
Asset turnover0.52x
Leverage & solvency
Liabilities / assets44.7%
Debt / equity0.56x
Current ratio2.98x
Interest coverage11.08x
Cash quality & payout
Operating cash flow / net income1.41x
Accruals ratio-6.0%
Payout ratio14.8%
Capex / revenue12.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q3*2026-09-30 | 2026Q2*2026-06-30 | 2026Q1*2026-03-31 | 2025Q4*2025-12-31 | 2025Q3*2025-09-30 | 2025Q2*2025-06-30 | 2025Q1*2025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.86B | $2.22B | $1.99B | $1.87B | $1.66B | $1.89B | $1.66B | $1.52B |
| Cost of revenue | $1.14B | $1.08B | $1.24B | $1.11B | $1.03B | $1.14B | $1.09B | $1.00B |
| Gross profit | $720.00M | $1.15B | $746.00M | $765.00M | $632.00M | $755.00M | $572.00M | $524.00M |
| SG&A expense | $87.00M | $89.00M | $103.00M | $91.00M | $88.00M | $101.00M | $84.00M | $78.00M |
| Operating income | $701.00M | $1.12B | $863.00M | $617.00M | $580.00M | $648.00M | $455.00M | $441.00M |
| Interest expense | $168.00M | $50.00M | $39.00M | $41.00M | $41.00M | $36.00M | $37.00M | $47.00M |
| Pretax income | $619.00M | $1.09B | $844.00M | $602.00M | $565.00M | $635.00M | $437.00M | $433.00M |
| Income tax | $99.00M | $224.00M | $168.00M | $107.00M | $105.00M | $143.00M | $86.00M | $41.00M |
| Net income | $436.00M | $727.00M | $615.00M | $404.00M | $353.00M | $386.00M | $312.00M | $328.00M |
| EBITDA | $934.00M | $1.34B | $1.09B | $845.00M | $797.00M | $880.00M | $676.00M | $662.00M |
| EPS (basic) | 2.88 | 4.74 | 3.99 | — | 2.19 | 2.37 | 1.85 | — |
| EPS (diluted) | 2.87 | 4.73 | 3.98 | — | 2.19 | 2.37 | 1.85 | — |
| Dividends declared per share | 0.60 | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 |
| Weighted avg. shares (diluted) | 151.60M | 153.90M | 154.50M | — | 161.20M | 163.10M | 168.80M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $2.82B | $2.48B | $2.04B | $1.98B | $1.84B | $1.69B | $1.41B | $1.61B |
| Receivables | $642.00M | $718.00M | $726.00M | $488.00M | $602.00M | $586.00M | $582.00M | $404.00M |
| Inventory | $416.00M | $415.00M | $371.00M | $383.00M | $367.00M | $316.00M | $351.00M | $314.00M |
| Current assets | $4.09B | $3.75B | $3.39B | $2.98B | $2.98B | $2.68B | $2.43B | $2.52B |
| PP&E, net | $6.90B | $6.76B | $6.72B | $6.71B | $6.83B | $6.74B | $6.60B | $6.74B |
| Goodwill | $2.49B | $2.49B | $2.49B | $2.49B | $2.49B | $2.49B | $2.49B | $2.49B |
| Intangibles | $449.00M | $460.00M | $470.00M | $473.00M | $480.00M | $488.00M | $499.00M | $507.00M |
| Total assets | $16.08B | $15.10B | $14.61B | $14.09B | $14.20B | $13.75B | $13.31B | $13.47B |
| Current liabilities | $1.37B | $772.00M | $958.00M | $887.00M | $1.31B | $830.00M | $939.00M | $818.00M |
| Long-term debt | $3.22B | $3.22B | $3.22B | $3.21B | $2.97B | $2.97B | $2.97B | $2.97B |
| Total debt | $3.22B | $3.22B | $3.22B | $3.21B | $2.97B | $2.97B | $2.97B | $2.97B |
| Total liabilities | $7.18B | $6.18B | $6.35B | $6.31B | $6.51B | $5.93B | $6.01B | $5.87B |
| Shareholders' equity | $5.73B | $5.75B | $5.34B | $4.84B | $4.85B | $4.96B | $4.78B | $4.99B |
| Net debt | $397.00M | $736.00M | $1.17B | $1.23B | $1.14B | $1.29B | $1.57B | $1.36B |
| Shares outstanding | — | — | — | 153.55M | — | — | — | 169.88M |
| Cash flow statement | ||||||||
| Operating cash flow | $1.17B | $878.00M | $496.00M | $539.00M | $1.06B | $563.00M | $586.00M | $420.00M |
| Capital expenditure | $282.00M | $271.00M | $223.00M | $226.00M | $347.00M | $245.00M | $132.00M | $197.00M |
| Free cash flow | $888.00M | $607.00M | $273.00M | $313.00M | $717.00M | $318.00M | $454.00M | $223.00M |
| Investing cash flow | -$282.00M | -$249.00M | -$225.00M | -$226.00M | -$339.00M | -$242.00M | -$126.00M | -$196.00M |
| Financing cash flow | -$544.00M | -$186.00M | -$199.00M | -$189.00M | -$562.00M | -$62.00M | -$671.00M | -$462.00M |
| Depreciation & amortization | $233.00M | $215.00M | $228.00M | $228.00M | $217.00M | $232.00M | $221.00M | $221.00M |
| Stock-based compensation | $9.00M | $9.00M | $11.00M | $10.00M | $13.00M | $12.00M | $10.00M | $10.00M |
| Dividends paid | $91.00M | $77.00M | $78.00M | $78.00M | $81.00M | $81.00M | $86.00M | $86.00M |
| Share buybacks | $357.00M | $225.00M | $28.00M | $345.00M | $360.00M | $216.00M | $444.00M | $375.00M |
Free plan shows the latest 8 periods; Pro shows all 74 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.